Abbott stock fell victim to an old earnings season truth: It's all about the guidance

cnbc.com/2025/07/17/abbott-stock-fell-victim-to-an-old-earnings-season-truth-its-all-about-the-guidance.html

Shares of Abbott Laboratories fell Thursday after the diversified health-care company delivered a solid second quarter but left investors disappointed with forward guidance. Revenue in the three months ended June 30 rose 7.4% to $11.14 billion, outpacing the $11.07 billion consensus…

This story appeared on cnbc.com, 2025-07-17 17:59:53.
The Entire Business World on a Single Page. Free to Use →